Pune, India -- (SBWIRE) -- 12/19/2018 -- Global Biologics Safety Testing Market is expected to grow significantly over the forecast period. The market held a market value of USD 2.79 billion in 2017 and is projected to register a CAGR of 13.6% over the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure that the product is safe and free of contaminants. Recently, CDER approved 46 novel drugs in 2017, whereas 22 in 2016.

Factors such as the growth in pharmaceutical and biotechnology industries, the increase in a number of drug launches, and increasing R&D investments in life science are expected to propel the growth of the market. However, stringent government regulations for the approval of biosimilars and high cost of drug development are likely to hamper the market growth over the forecast period.

Key Players:

Some of the prominent players in the global biologics safety testing market are Merck KGaA, Charles River Laboratories, Sartorius AG, Lonza Group Ltd., SGS S.A., Thermo Fisher Scientific Inc, Wuxi Apptec, Cytovance Biologics, Inc., Avance Biosciences Inc., and Eurofins Scientific.

Get Sample Research Report at https://www.marketresearchfuture.com/sample_request/6800

Segmentation:

The global biologics safety testing market has been segmented into product, test type, and application.

Based on product, the market is segmented into kits and reagents, services, and instruments. The kits and reagents segment accounted for the largest share of the market in 2017.

Based on test type, the market is segmented into sterility tests, endotoxin tests, cell line authentication and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and others.

Based on application, the market is segmented into vaccine and therapeutics development, blood and blood-related products testing, cellular and gene therapy, tissue and tissue-related products testing, and stem cell research.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The biologics safety testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European biologics safety testing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The biologics safety testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biologics safety testing market in the Middle East and Africa has been segmented into the Middle East and Africa.

Intended Audience

Biologics safety testing products manufacturers and vendors
Various research and consulting firms
Biologics safety testing Distributors
Biologics safety testing services providers

Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/biologics-safety-testing-market-6800

Growing pharmaceutical and biotech industry and increasing demand for biological products are expected to drive the growth of the market. However, stringent government regulations for the approval of biosimilars and high cost of drug development are likely to hamper the market growth over the forecast period.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Biologics Safety Testing Market, By Product

Chapter 7. Global Biologics Safety Testing Market, By Test Type

Chapter 8. Global Biologics Safety Testing Market, By Application

Chapter 9. Global Biologics Safety Testing Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12 MRFR Conclusion

Chapter 13. Appendix

LIST OF TABLES
LIST OF FIGURES

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global biologics safety testing market owing to a well-established player, new product launches, and increasing demand for biological products.

Europe is expected to hold the second largest position in the global biologics safety testing market.

The biologics safety testing market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the growth in pharmaceutical and biotech industries.

The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector.

Inquire for Discount at https://https://www.marketresearchfuture.com/check-discount/6800/check-discount/6800

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.